Retreatment with 24-week course of interferon-alpha for patients with chronic hepatitis C

被引:2
作者
Hagiwara, H [1 ]
Hayashi, N [1 ]
Oshita, M [1 ]
Katayama, K [1 ]
Kasahara, A [1 ]
Fusamoto, H [1 ]
Kamada, T [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT MED 1,SUITA,OSAKA 565,JAPAN
来源
INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1996年 / 5卷 / 02期
关键词
hepatitis C virus RNA; antiviral therapy; interferon therapy; level of viremia;
D O I
10.1016/0928-4346(96)00291-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Twenty-nine patients with chronic hepatitis C were retreated with a 24-week course of natural interferon-a to evaluate the efficacy of retreatment with interferon for patients who were resistant to previous therapy. At 6 months after the end of retreatment, three patients (10%) had achieved sustained alanine aminotransferase normalization and sustained clearance of hepatitis C virus RNA in serum. Fifteen patients (52%) showed alanine aminotransferase normalization during retreatment but suffered from relapse during the 24 weeks after retreatment. In 11 patients (38%), no significant decrease of alanine aminotransferase was observed during and after retreatment. Three of ten patients with hepatitis C virus RNA of 2.3 x 10(5) equivalents/ml or less became sustained responders but none of the patients with a higher virus level achieved a sustained response. These results indicate that retreatment with a 24-week course of interferon is not efficient and other approaches are needed to attain a higher rate of sustained response, especially in patients with high viral load.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 18 条
  • [1] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL
    DAVIS, GL
    BALART, LA
    SCHIFF, ER
    LINDSAY, K
    BODENHEIMER, HC
    PERRILLO, RP
    CAREY, W
    JACOBSON, IM
    PAYNE, J
    DIENSTAG, JL
    VANTHIEL, DH
    TAMBURRO, C
    LEFKOWITCH, J
    ALBRECHT, J
    MESCHIEVITZ, C
    ORTEGO, TJ
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1501 - 1506
  • [2] RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DIBISCEGLIE, AM
    MARTIN, P
    KASSIANIDES, C
    LISKERMELMAN, M
    MURRAY, L
    WAGGONER, J
    GOODMAN, Z
    BANKS, SM
    HOOFNAGLE, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1506 - 1510
  • [3] DETECTION OF HEPATITIS-C-VIRUS RNA IN CHRONIC NON-A, NON-B LIVER-DISEASE
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    HIRAMATSU, N
    UEDA, K
    TAKEHARA, T
    YUKI, N
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. GASTROENTEROLOGY, 1992, 102 (02) : 692 - 694
  • [4] QUANTITATION OF HEPATITIS-C VIRUS-RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS AND PATIENTS WITH TYPE-C CHRONIC LIVER-DISEASE
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    NAITO, M
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. HEPATOLOGY, 1993, 17 (04) : 545 - 550
  • [5] DETECTION OF HEPATITIS-C VIRUS-RNA IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    UEDA, K
    TAKEHARA, T
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. HEPATOLOGY, 1992, 15 (01) : 37 - 41
  • [6] QUANTITATIVE-ANALYSIS OF HEPATITIS-C VIRUS-RNA IN SERUM DURING INTERFERON ALFA THERAPY
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    TAKEHARA, T
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. GASTROENTEROLOGY, 1993, 104 (03) : 877 - 883
  • [7] HOFFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575
  • [8] A MULTIVARIATE-ANALYSIS OF RISK-FACTORS FOR HEPATOCELLULAR CARCINOGENESIS - A PROSPECTIVE OBSERVATION OF 795 PATIENTS WITH VIRAL AND ALCOHOLIC CIRRHOSIS
    IKEDA, K
    SAITOH, S
    KOIDA, I
    ARASE, Y
    TSUBOTA, A
    CHAYAMA, K
    KUMADA, H
    KAWANISHI, M
    [J]. HEPATOLOGY, 1993, 18 (01) : 47 - 53
  • [9] KANAZAWA Y, 1994, HEPATOLOGY, V20, P112
  • [10] ABILITY OF PROLONGED INTERFERON TREATMENT TO SUPPRESS RELAPSE AFTER CESSATION OF THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    KASAHARA, A
    HAYASHI, N
    HIRAMATSU, N
    OSHITA, M
    HAGIWARA, H
    KATAYAMA, K
    KATO, M
    MASUZAWA, M
    YOSHIHARA, H
    KISHIDA, Y
    SHIMIZU, Y
    INOUE, A
    FUSAMOTO, H
    KAMADA, T
    [J]. HEPATOLOGY, 1995, 21 (02) : 291 - 297